ロード中...
Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease
The care of inflammatory bowel disease has changed considerably with the introduction of a number of immunosuppressants including anti-metabolite and anti-TNF therapies. While efficacious, these medications also carry important risks, notably the potential risk of lymphoma. This risk is one of the m...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925472/ https://ncbi.nlm.nih.gov/pubmed/20594135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/eci.10.36 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|